Russ Lebovitz

Russ Lebovitz is a seasoned executive with extensive experience in the healthcare and biotechnology sectors. Currently serving as CEO of Amprion Inc. since July 2007, Russ leads efforts aimed at early detection of neurodegenerative diseases like Alzheimer's and Parkinson's. Additionally, Russ holds the position of Director at Skincential Sciences, Inc., guiding teams in developing innovative skincare products. As Global Venture Partner at BootstrapLabs and Managing Partner at Suma Ventures, Russ focuses on venture capital investments in applied artificial intelligence and life sciences, respectively. Past roles include President & CEO at Marval Biosciences and Tego Biosciences, where advancements in medical imaging technology were prioritized. Russ's academic credentials include an MD and PhD in Molecular Biology and Pathology from the University of Michigan and Washington University School of Medicine in St. Louis.